256 related articles for article (PubMed ID: 38267771)
21. Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review.
Albuquerque A; Stockdale CK; Heller D; Bornstein J; Roberts JM; Preti M; Poynten IM; Vieira-Baptista P
J Low Genit Tract Dis; 2022 Jan; 26(1):32-37. PubMed ID: 34670242
[TBL] [Abstract][Full Text] [Related]
22. Screening Women for Anal Cancers: Guidance for Health Care Professionals.
Vegunta S; Shah AA; Whited MH; Long ME
Am J Gastroenterol; 2021 Mar; 116(3):509-516. PubMed ID: 33606380
[TBL] [Abstract][Full Text] [Related]
23. Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers.
Clarke MA; Wentzensen N
Cancer Cytopathol; 2018 Jul; 126(7):447-460. PubMed ID: 29797691
[TBL] [Abstract][Full Text] [Related]
24. Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts.
Ito T; Takayanagi D; Sekine S; Hashimoto T; Shimada Y; Matsuda M; Yamada M; Hamamoto R; Kato T; Shida D; Kanemitsu Y; Boku N; Kohno T; Takashima A; Shiraishi K
Sci Rep; 2023 Mar; 13(1):3587. PubMed ID: 36869079
[TBL] [Abstract][Full Text] [Related]
25. Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors.
Bidinotto LT; Véo CA; Loaiza EA; De França AP; Lorenzi AT; Rosa LA; De Oliveira CM; Levi JE; Scapulatempo-Neto C; Longatto-Filho A; Reis RM
Mol Med Rep; 2016 Oct; 14(4):3791-7. PubMed ID: 27573925
[TBL] [Abstract][Full Text] [Related]
26. Anal cytological lesions and HPV infection in individuals at increased risk for anal cancer.
Donà MG; Benevolo M; Latini A; Rollo F; Colafigli M; Frasca M; Zaccarelli M; Giglio A; Moretto D; Pescarmona E; Cristaudo A; Giuliani M
Cancer Cytopathol; 2018 Jul; 126(7):461-470. PubMed ID: 29694716
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
Brogden DRL; Walsh U; Pellino G; Kontovounisios C; Tekkis P; Mills SC
Int J Colorectal Dis; 2021 Feb; 36(2):213-226. PubMed ID: 32979069
[TBL] [Abstract][Full Text] [Related]
28. Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes.
O'brien SJ; Gaskins JT; Ellis CT; Martin BA; Mcdowell J; Gondim DD; Galandiuk S
Cancer Med; 2023 May; 12(10):11462-11474. PubMed ID: 36991580
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of high-risk human papillomavirus DNA and p16
Obermueller T; Hautekiet J; Busto MP; Reynders D; Belgioia L; Cats A; Gilbert DC; Koerber SA; Mai S; Meulendijks D; Rödel F; Yhim HY; Hetjens S; Weiß C; Rasmussen CL; Urbute A; Verdoodt F; Kjaer SK; Reuschenbach M; Goetghebeur E; von Knebel Doeberitz M; Arbyn M; Prigge ES
Eur J Cancer; 2021 Nov; 157():165-178. PubMed ID: 34517306
[TBL] [Abstract][Full Text] [Related]
30. Anal squamous cell carcinoma: an evolution in disease and management.
Osborne MC; Maykel J; Johnson EK; Steele SR
World J Gastroenterol; 2014 Sep; 20(36):13052-9. PubMed ID: 25278699
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
[TBL] [Abstract][Full Text] [Related]
33. Trends in incidence and survival for anal cancer in New South Wales, Australia, 1972-2009.
Soeberg MJ; Rogers K; Currow DC; Young JM
Cancer Epidemiol; 2015 Dec; 39(6):842-7. PubMed ID: 26651444
[TBL] [Abstract][Full Text] [Related]
34. A 2020 update of anal cancer: the increasing problem in women and expanding treatment landscape.
Lum C; Prenen H; Body A; Lam M; Segelov E
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):665-680. PubMed ID: 32458709
[TBL] [Abstract][Full Text] [Related]
35. Anal Cancer: Emerging Standards in a Rare Disease.
Eng C; Ciombor KK; Cho M; Dorth JA; Rajdev LN; Horowitz DP; Gollub MJ; Jácome AA; Lockney NA; Muldoon RL; Washington MK; O'Brian BA; Benny A; Lebeck Lee CM; Benson AB; Goodman KA; Morris VK
J Clin Oncol; 2022 Aug; 40(24):2774-2788. PubMed ID: 35649196
[TBL] [Abstract][Full Text] [Related]
36. Local excision and treatment of early node-negative anal squamous cell carcinomas in a highly HIV prevalent population.
Brogden DRL; Kontovounisios C; Chong I; Tait D; Warren OJ; Bower M; Tekkis P; Mills SC
Tech Coloproctol; 2021 Sep; 25(9):1027-1036. PubMed ID: 34117969
[TBL] [Abstract][Full Text] [Related]
37. Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model.
Bu LL; Li YC; Yu GT; Liu JF; Deng WW; Zhang WF; Zhang L; Sun ZJ
Sci Rep; 2017 Jul; 7(1):6629. PubMed ID: 28747781
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers in anal cancer: from biological understanding to stratified treatment.
Jones CM; Goh V; Sebag-Montefiore D; Gilbert DC
Br J Cancer; 2017 Jan; 116(2):156-162. PubMed ID: 27923035
[TBL] [Abstract][Full Text] [Related]
39. An overview of anal intraepithelial neoplasia.
Buzard CL; Rizzolo D
JAAPA; 2018 Jul; 31(7):1-5. PubMed ID: 29957613
[TBL] [Abstract][Full Text] [Related]
40. Long-standing Crohn's disease and its implication on anal squamous cell cancer management.
Lightner AL; Moncrief SB; Smyrk TC; Pemberton JH; Haddock MG; Larson DW; Dozois EJ; Mathis KL
Int J Colorectal Dis; 2017 May; 32(5):661-666. PubMed ID: 28293746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
